Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Engelhard Arzneimittel is a family-owned German pharmaceutical company that specializes in the development and manufacture of over-the-counter (OTC) medicines, with a strong focus on phytopharmaceuticals. Established in 1872, the company has become a global leader in respiratory health through its flagship brands Prospan, an ivy-based cough treatment, and Isla, a range of throat lozenges. The company integrates research, development, and production at its headquarters in Niederdorfelden to ensure high-quality standards for its evidence-based natural medicines. Engelhard's portfolio also extends into dermatology and digestive health, serving patients in over 100 countries through extensive distribution partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Engelhard Pharma.